PTGS2 and cancer: Further studies exploring the precise mechanism by which prostaglandins influence E1A-induced apoptosis, and confirmation of synergistic effects between E1A gene therapy and COX-2 inhibitor treatment in cancer xenograft models, are needed to establish conclusively that COX-2 inhibitors can overcome resistance to E1A-induced apoptosis.